Birrer MJ - Search Results

1

Na YJ, Farley J, Zeh A, del Carmen M, Penson R, Birrer MJ. Na YJ, et al. Among authors: birrer mj. Int J Gynecol Cancer. 2009 Dec;19 Suppl 2:S21-9. doi: 10.1111/IGC.0b013e3181c2aeb5. Int J Gynecol Cancer. 2009. PMID: 19955910 Review.

2

Genomic analysis of epithelial ovarian cancer.

Farley J, Ozbun LL, Birrer MJ. Farley J, et al. Among authors: birrer mj. Cell Res. 2008 May;18(5):538-48. doi: 10.1038/cr.2008.52. Cell Res. 2008. PMID: 18427574 Free PMC article. Review.

3

Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer.

Rauh-Hain JA, Guseh SH, Esselen KM, Growdon WB, Schorge JO, Horowitz NS, Krasner CN, del Carmen MG, Birrer MJ, Dizon DS. Rauh-Hain JA, et al. Among authors: birrer mj. Int J Gynecol Cancer. 2013 Sep;23(7):1219-25. doi: 10.1097/IGC.0b013e31829f17c9. Int J Gynecol Cancer. 2013. PMID: 23975042

4

Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer.

Del Carmen MG, Supko JG, Horick NK, Rauh-Hain JA, Clark RM, Campos SM, Krasner CN, Atkinson T, Birrer MJ. Del Carmen MG, et al. Among authors: birrer mj. Cancer. 2016 Nov 15;122(21):3297-3306. doi: 10.1002/cncr.30196. Epub 2016 Jul 15. Cancer. 2016. PMID: 27421044 Free article. Clinical Trial.

5

Real-Time Single-Walled Carbon Nanotube-Based Fluorescence Imaging Improves Survival after Debulking Surgery in an Ovarian Cancer Model.

Ceppi L, Bardhan NM, Na Y, Siegel A, Rajan N, Fruscio R, Del Carmen MG, Belcher AM, Birrer MJ. Ceppi L, et al. Among authors: birrer mj. ACS Nano. 2019 May 28;13(5):5356-5365. doi: 10.1021/acsnano.8b09829. Epub 2019 Apr 25. ACS Nano. 2019. PMID: 31009198

6

Clear cell carcinoma of the ovary: a review of the literature.

del Carmen MG, Birrer M, Schorge JO. del Carmen MG, et al. Gynecol Oncol. 2012 Sep;126(3):481-90. doi: 10.1016/j.ygyno.2012.04.021. Epub 2012 Apr 21. Gynecol Oncol. 2012. PMID: 22525820 Review.

7

Carcinosarcoma of the ovary: a review of the literature.

del Carmen MG, Birrer M, Schorge JO. del Carmen MG, et al. Gynecol Oncol. 2012 Apr;125(1):271-7. doi: 10.1016/j.ygyno.2011.12.418. Epub 2011 Dec 8. Gynecol Oncol. 2012. PMID: 22155675 Review.

8

Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a Gynecologic Oncology Group study.

Farley J, Smith LM, Darcy KM, Sobel E, O'Connor D, Henderson B, Morrison LE, Birrer MJ; Gynecologic Oncology Group. Farley J, et al. Among authors: birrer mj. Cancer Res. 2003 Mar 15;63(6):1235-41. Cancer Res. 2003. PMID: 12649182

9

Clear cell cancer of the ovary.

Penson RT, Dizon DS, Birrer MJ. Penson RT, et al. Among authors: birrer mj. Curr Opin Oncol. 2013 Sep;25(5):553-7. doi: 10.1097/CCO.0b013e328363e0c7. Curr Opin Oncol. 2013. PMID: 23942300 Review.

10

Variation in resource utilization associated with the surgical management of ovarian cancer.

Rauh-Hain JA, Hidrue MK, Gaccione P, Melamed A, Meyer LA, Keating NL, Giordano SH, Rice LW, Birrer MJ, Del Carmen MG. Rauh-Hain JA, et al. Among authors: birrer mj. Gynecol Oncol. 2019 Mar;152(3):587-593. doi: 10.1016/j.ygyno.2018.12.013. Epub 2018 Dec 19. Gynecol Oncol. 2019. PMID: 30579568 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

443 results

Search Page